RESMED INC (RMD) Stock Price & Overview
NYSE:RMD • US7611521078
Current stock price
The current stock price of RMD is 220.47 USD. Today RMD is down by -0.91%. In the past month the price decreased by -13.97%. In the past year, price increased by 0.24%.
RMD Key Statistics
- Market Cap
- 32.118B
- P/E
- 21.45
- Fwd P/E
- 17.95
- EPS (TTM)
- 10.28
- Dividend Yield
- 1.08%
RMD Stock Performance
RMD Stock Chart
RMD Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to RMD. When comparing the yearly performance of all stocks, RMD is a bad performer in the overall market: 67.42% of all stocks are doing better.
RMD Fundamental Analysis
ChartMill assigns a fundamental rating of 7 / 10 to RMD. RMD gets an excellent profitability rating and is at the same time showing great financial health properties.
RMD Earnings
On January 29, 2026 RMD reported an EPS of 2.81 and a revenue of 1.42B. The company beat EPS expectations (2.15% surprise) and beat revenue expectations (0.91% surprise).
RMD Forecast & Estimates
25 analysts have analysed RMD and the average price target is 302.83 USD. This implies a price increase of 37.35% is expected in the next year compared to the current price of 220.47.
For the next year, analysts expect an EPS growth of 16.4% and a revenue growth 9.97% for RMD
RMD Groups
Sector & Classification
RMD Financial Highlights
Over the last trailing twelve months RMD reported a non-GAAP Earnings per Share(EPS) of 10.28. The EPS increased by 16.29% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 27.53% | ||
| ROA | 17.47% | ||
| ROE | 23.51% | ||
| Debt/Equity | 0.06 |
RMD Ownership
RMD Latest News, Press Relases and Analysis
RMD Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 18.1 | 181.708B | ||
| ISRG | INTUITIVE SURGICAL INC | 44.29 | 160.771B | ||
| SYK | STRYKER CORP | 21.65 | 125.308B | ||
| BSX | BOSTON SCIENTIFIC CORP | 19.78 | 104.125B | ||
| EW | EDWARDS LIFESCIENCES CORP | 26.33 | 47.684B | ||
| BDX | BECTON DICKINSON AND CO | 11.33 | 44.812B | ||
| IDXX | IDEXX LABORATORIES INC | 37.66 | 44.453B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 13.39 | 32.604B | ||
| DXCM | DEXCOM INC | 24.49 | 25.435B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.45 | 17.329B | ||
| HOLX | HOLOGIC INC | 15.41 | 16.897B | ||
| PODD | INSULET CORP | 32.21 | 15.355B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About RMD
Company Profile
ResMed, Inc. engages in providing digital health and cloud-connected medical devices. The company is headquartered in San Diego, California and currently employs 10,600 full-time employees. The Company, through its subsidiaries, in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Its segments include Sleep and Breathing Health segment and the Residential Care Software segment. The company also operates a Software as a Service (SaaS) business in the United States and Germany that includes out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. Its products and solutions are designed to improve patients' quality of life and reduce the impact of chronic disease. Its cloud-based digital health software applications, along with its devices, are designed to provide connected care.
Company Info
IPO: 1995-06-01
RESMED INC
9001 Spectrum Center Blvd
San Diego CALIFORNIA 92123 US
CEO: MichaelJ.Farrell
Employees: 10600
Phone: 18587462400
RESMED INC / RMD FAQ
What does RESMED INC do?
ResMed, Inc. engages in providing digital health and cloud-connected medical devices. The company is headquartered in San Diego, California and currently employs 10,600 full-time employees. The Company, through its subsidiaries, in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Its segments include Sleep and Breathing Health segment and the Residential Care Software segment. The company also operates a Software as a Service (SaaS) business in the United States and Germany that includes out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. Its products and solutions are designed to improve patients' quality of life and reduce the impact of chronic disease. Its cloud-based digital health software applications, along with its devices, are designed to provide connected care.
Can you provide the latest stock price for RESMED INC?
The current stock price of RMD is 220.47 USD. The price decreased by -0.91% in the last trading session.
Does RMD stock pay dividends?
RESMED INC (RMD) has a dividend yield of 1.08%. The yearly dividend amount is currently 2.12.
What is the ChartMill rating of RESMED INC stock?
RMD has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 7 out of 10.
What is the analyst forecast for RMD stock?
25 analysts have analysed RMD and the average price target is 302.83 USD. This implies a price increase of 37.35% is expected in the next year compared to the current price of 220.47.
How many employees does RESMED INC have?
RESMED INC (RMD) currently has 10600 employees.
When does RESMED INC (RMD) report earnings?
RESMED INC (RMD) will report earnings on 2026-04-23.